chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sharp chest pains began within 2 hours of receiving vaccination making breathing difficult and causing continuous coughing. No phlegm present. Fatigue set it and was asleep for ~42 of the next 48 hours, waking intermittently to hydrate with water and use restroom, but took no food until Thursday. Chest pains and headache still present at time of reporting. Will report to urgent care should symptoms flare again, as I have experienced inflammation of the heart and lung tissues previously and will document any such case with the hospital that administered the vaccine.
Late menstrual period; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the right arm on 30Apr2021 at 13:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 13:30(at the age of 20-year-old) as a single dose for COVID-19 immunisation. On 25May2021 at 00:00 the patient experienced late menstrual period, which is not typical for the patient. Therapeutic measures were not taken as a result of the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event late menstrual period was unknown at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
My heart keep racing non stop for a week already; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (My heart keep racing non stop for a week already) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (My heart keep racing non stop for a week already). At the time of the report, PALPITATIONS (My heart keep racing non stop for a week already) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitent informations were reported. No Treament informations were reported.   Reporter did not allow further contact
Day 1 (Sept 3) arm pain immediately that worsened over the day.  chills and headache within a few hours, general sense of being unwell and tired Day 2 (Wednesday, Sept 4) headache, chills, fever (99.6), lots of fatigue.  Not up to doing anything and mostly slept.  Arm pain such that the left arm could be used for nothing.  Could barely lift it.  Very tender to touch.   Day 3 (Thursday, Sept 5), woke up feeling better, headache free, and did a lot more normal activities today but was worn out easily.  Did have sore throat that was first noticed upon waking.  Noticed joint pain (unusual) in knees and shoulders. Arm pain about the same or slightly improved.  Took 2 Advil.  It seemed to help with joint pain  PM of Day 3...woke up to go to the bathroom and had very bad headache and nausea Day 4 (Friday Sept 6) felt worse than Th AM but better than Wednesday.  Sore throat still present.  Felt shaky and chills but no fever.  Headache comes and goes.  Arm pain significantly reduced.  Didn't do much this day    PM of Day 4: noticed red blotchy rash on left arm where shot was given Day 5 (SAturday, Sept 7) the red rash itches now. Arm pain not totally gone but not impacting activities to any great degree.  Stamina low.  Tire easily.  Otherwise don't feel especially sick.  Sore throat still present but better.    Still monitoring and disappointed (and a bit worried) that so many days later I don't feel right.
Patient received his first dose of Pfizer covid vaccine last month.  Within the following week, pt developed extreme weakness in his legs and had difficulty walking without assistance.  He was admitted to Hospital and underwent labs and MRIs.  Workup did not show any cause for his symptoms.  He was discharged home and he regained full strength after a week.  He received his second dose on 12/1/2021.  The next days, he started having weakness again.  he was seen in my clinic yesterday 12/7/21, and he needs to use a cane to help him walk.
I couple weeks after I received the vaccine I started couching, feeling fatigued and having weight loss. I took two at home COVID-19 test that came back negative. I did telehealth visits with my doctor thinking I had acid reflux causing my coughing. I went in to see her in the early part on 2022 I had x-rays and CT scans were we found a mass on my lung and kidney. I was referred to a Pulmonologist. The Pulmonologist wants to do a biopsy but I asked if we could wait six months to see if would remedy itself.
Patient reports soreness following administration of the vaccine, which continued into the weekend.  Along with the soreness was redness and swelling of the right arm and fingers.  On Wednesday, Thursday, and Friday of the following week, patient states it felt like his arm was "broken" and had limited mobility in the right arm and wrist.  In addition, he experienced pain the right hip and leg (mainly the joints).  He also stated he had shortness of breath (excercise induced - walking) for approximately 2 days.  Treatment of the symptoms included ice therapy and use of ointment for joint/arthritis pain.  As of today, day fifteen following administration of the 3rd dose of Twinrix, patient states he is "getting better, but still has tenderness in his right elbow and has not gained full strength in the right arm yet."  Patient is in the process of setting up an appointment to see his primary care physician.
Information has been received from a physician concerning a 14 year old female who was vaccinated with an injection of her third dose of Gardasil.  Subsequently the patient experienced a fever one week after getting the third dose of Gardasil.  The patient's fever persisted and she sought unspecified medical attention.  Additional information has been requested.
Pt.  had flu vaccine 9/1/11 on 9/2/11 grandfather spoke with dr had a lump 2 inches in diameter at the site of vaccine. Not seen in office. Reported over phone.
Feeling very sick; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling very sick) and VOMITING (Throwing up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced MALAISE (Feeling very sick) and VOMITING (Throwing up). At the time of the report, MALAISE (Feeling very sick) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided.  Treatment information was not provided.
Information has been received from a physician concerning a female who was vaccinated with the third dose of GARDASIL.  Per the reporter, the mother of the patient mentioned that the patient experienced fatigue after receiving the third dose of GARDASIL.  The patient sought unspecified medical attention in the physician's office.  Subsequently, the patient recovered "after a few weeks."  The reporter noted that the vaccine series was administered by the patient's pediatrician and that is why a lot number was not available.  No further information was provided.  Follow-up information from B Form (21-FEB-2008):  Patient had malaise develop with the third dose of GARDASIL.  All labs including TSH were normal; physical exam was also normal.  Additional information has been requested.
fever; headache; It was extremely uncomfortable and I was non functioning; body aches; This is a spontaneous report from a non-contactable consumer (patient) reporting herself.  A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9269), via unspecified route of administration in the left arm, on 12Feb2021 at 02:00 (At the age of 48-year-old), as dose 2, single for COVID-19 Immunization. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient was not a pregnant at the time of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL3247), via unspecified route of administration in the left arm, on 22Jan2021, as dose 1, single for COVID-19 Immunization. The patient had no covid prior vaccination and not tested for covid post vaccination. It was reported that, on 13Feb2021 at 02:00 AM, the patient experienced fever, body aches and headache, and the events were lasted for 24 hours. The patient did not take any pain reliever, but it was extremely uncomfortable, and he was non-functioning. Even 10 days later, she still has headache. The outcome of the events was recovered with lasting effects.   No follow-up attempts are possible. No further information is expected.
This spontaneous report has been received from a medical assistant referring to multiple unspecified patients of unknown age and gender. Information regarding the patients' medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On multiple unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot # M020101, expiration date 07-MAR-2019 and ROTATEQ lot # N009948, expiration date 21-OCT-2018, for prophylaxis. The vaccines underwent a temperature excursion between 2°C to 8°C (8.4°C), during a time frame of 15 minutes, which was called by a data logger. Previous temperature excursions included 9°C to 25°C (10°C) for 4 hours and 15 minutes. No adverse effects were reported.
Shingles; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 47-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6955), via an unspecified route of administration, administered in Arm Left on 20Mar2021 17:45 (at the age of 47-years-old) as dose 1, single for COVID-19 immunisation. Medical history included chickenpox virus from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE SODIUM), fluticasone propionate, salmeterol xinafoate (ADVAIR), fluticasone (FLUTICASONE) taken for an unspecified indication, start and stop date were not reported. The patient previously took Symbicort and experienced hypersensitivity. The patient experienced shingles on 23Mar2021. Patient received treatment Medication for the chickenpox virus, pain and gel. Patient visited Emergency room/department or urgent care. The outcome of the events was reported as recovering.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On unknown dates approximately in 2015 (reported as since 20-FEB-2015), the patients were vaccinated with doses of PEDVAXHIB (dose, frequency, route of administration, lot# and expiration date were not reported), which were exposed to a temperature outside of the recommended range on 20-FEB-2015. No adverse experience had been observed or reported. Product quality complaint (PQC) was not involved. This is one of two reports received from the same reporter. Additional information has been requested.
The patient has a history of prostate cancer and rheumatoid arthritis. He was brought to the ED by EMS on 9/25/23 for evaluation after a fall and overall feeling weak. In the ED, the patient also reported weakness, trouble breathing, slight fever, cough, and nasal congestion. A COVID PCR test in the ED resulted positive. Ultimately, the patient was admitted 9/25/23 - 9/27/23, with discharge diagnosis including COVID pneumonia and acute respiratory failure secondary to COVID, among other diagnoses. During admission, the patient did require supplemental oxygen however was weaned to room air. The patient has received 4 doses of the Pfizer monovalent COVID vaccine (1/21/2021; 2/11/2021; 12/1/2021; 4/28/2022) and one dose of the Pfizer Bivalent COVID vaccine (10/7/2022).
pt felt warm, screaming, father put pt in tub then eyes rolled back, not responsive 1 1/2 min, became shakey according to father. Took pt to ER where T 102.6 (R), No further treatment  L.P. done in ER, glu-83(high), no bacteria found
15hrs post injection, muscle aches, joint pain; 15hrs post injection, muscle aches, joint pain; injection site pain 12hrs post injection; intense chills/shivering 12hrs post injection #2; This is a spontaneous report from a contactable nurse.  A 41-year-old non-pregnant female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3248 and Expiration Date: Apr2021), via an unspecified route of administration in the left arm on 15Jan2021 at 12:00 at 41-years-old at a single dose for COVID-19 immunization in a hospital.  Medical history included asthma from an unknown date and unknown if ongoing, gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing, thoracic outlet syndrome (arterial/neurogenic) from an unknown date and unknown if ongoing, Allergies to Iodine based contrast from an unknown date and unknown if ongoing, sulfonamide allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunization on 28Dec2020 at 12:00 at 41-years-old and experienced no symptoms (first dose; Lot number: EJ1685, EXP: Mar2021, vaccine location: left arm). Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), levocetirizine dihydrochloride (XYZAL), omeprazole (PROTONIX); all taken for an unspecified indication from an unspecified date to an unspecified date; within two weeks of vaccination.  On 16Jan2021 at 00:00, the patient experienced: injection site pain 12hrs post injection, intense chills/shivering 12hrs post injection #2. On 16Jan2021 at 03:00, the patient experienced: 15hrs post injection, muscle aches, joint pain. Therapeutic measures were taken as a result of intense chills/shivering 12hrs post injection #2: relieved by 500 mg of paracetamol (TYLENOL) upon onset of chills (as reported). The clinical outcome of the events was recovering (as reported). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Very sore arm at site of injection, pain radiating down arm and into shoulder. Next day, in the afternoon, I got the shivers. Overnight, I woke at 2 am with 101.3 fever, which lasted 3 hours.
Back hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious), outcome "unknown", described as "Back hurt".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
While standing in the observation area post vaccination patient experienced syncopal episode with LOC. He states he doesn't even recall what happened. According to the patient, he was on his phone and he remembers waking up on the floor. He denies having light headedness/dizziness, or CP prior to LOC. Imaging was done upon arrival to ER, which revealed incidental finding of sella/suprasellar mass encroaching on the optic chiasm.
This spontaneous report as received from a health professional refers to a 19 year old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date in March 2016 (reported as "some time in March 2016"), the patient was vaccinated with a first dose in series of PROQUAD (dose, route of administration, lot# and expiration date were not reported) concomitantly with a first dose of VARIVAX (Merck) (dose, route of administration, lot# and expiration date were not reported) (which was verified by the reporter). No adverse effects were reported. Additional information has been requested.
intense abdominal pains, diahrrhea, headaches, migraines, loss of appetite, fatigue and moderate to intense join pain for months and now years since vaccinations.  did get hpv #1 and vairvax on same day - previous report submitted (e42249 vares file) din't have the hpv vaccination recorded.
Pt developed a significant chicken pox rash.  As of 11/26/2014 pt has not recovered from that rash.  He was examined in our office and mother asked that we report this reaction because of the severity of the rash.
the patient complained of feeling lightheaded a few minutes after receiving her vaccine.  She was observed for an additional 30 minutes.  Vital signs were recorded.  She was discharged to home in stable condition
The following day pt was lethargic for approx 6 hrs & 2hrs had an inc temp of 104;
I developed swelling (pitting edema) and pain in my left lower extremity, as well as tenderness, redness, and induration along the course of my greater saphenous vein.  This occurred  three weeks after my Moderna booster.  I was seen three days later in the emergency department and was diagnosed with both superficial thrombophlebitis of my greater saphenous vein and a deep venous thrombosis (DVT) of my left common femoral vein.  I was started on Xarelto that day.  One month later, my symptoms persist, although they are slightly improved.
This spontaneous report was received from a Licensed Practical Nurse, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 07-JUL-2016, the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # K021030; expiration date 22-JUN-2016 (dose, dose number and anatomical location were not reported). Concomitant medications were not reported. No adverse effects were reported. No Product Quality Complaint was involved. Additional information has been requested.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), in Nov2021 as dose 2 (booster), single (Batch/Lot number: unknown) at the age of 36 years for covid-19 immunisation; coviD-19 vaccine janssen (COVID-19 VACCINE JANSSEN), in Mar2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: The covid test has rebounded after finishing the treatment and has remained positive for a week. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
So within a few minutes I had numbness and coldness in the entire arm and a headache. Then maybe 10 hrs later, nausea, numbness, body aches, joint pain, headache and fatigue.
7/13/2021 - ACUTE RESPIRATORY FAILURE - J96.00 -  7/14/2021 - HYPOXIA - R09.02 7/16/2021 - ACUTE HYPOXEMIC RESPIRATORY FAILURE - J96.01
My shoulder was sore, which was expected, but the level of lethargy was not. The symptoms to me were very flu-like: achy muscles, weakness and extremely tired for at least two days. This is my second shingles shot and the first one was even more pronounced. It really knocked the stuffing out of me. All I wanted to do was lay around the house and sleep. It passed after a couple of days, but it took me out of circulation for a good 48 hours.
3hr p/vax pt w/fussiness & fever, screaming & erythema & tenderness surrounding vax site;improved p/1dose of DPH p/vax;
After my terrible chills and fever were gone I got my period 2 weeks early.  It was a normal period however only 5 days later I got ANOTHER period.   This was was much heavier than normal with done quarter sized blood clots.   It lasted 7 days.
Information has been received regarding a case in litigation from a lawyer and a male patient referring to himself. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The male patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 26 FEB 2015, the patient was administered the ZOSTAVAX by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated at a clinic by an unspecified healthcare provider for the following injury resulting from the ZOSTAVAX use: Herpes zoster. The patient claims damages including: injury to self, loss of consortium, loss of services, and economic losses. The outcome of the shingles was unknown. Additional information has been requested.
This spontaneous report was received from a physician refers to a female patient (age unknown) with asthma, peanut allergy, broccoli allergy and wheat allergy. On an unknown date, the patient was vaccinated with first dose of GARDASIL (120 microgram) (lot number, dose, frequency and route were not reported). On an unknown date, the patient was vaccinated with second dose of GARDASIL (120 microgram) (lot number, dose, frequency and route were not reported. The vaccination dates were according to the vaccination schedule. Concomitant therapies included FLONASE, ASMANEX TWISTHALER and albuterol. On an unknown date, the patient developed "a sensation of itching and possible swelling in her throat 30 minutes to one hour after receiving her second dose." The patient sought medical attention and was not treated for the events. Laboratories were not performed. On unspecific date, the patient recovered from a sensation of itching and possible swelling in her throat. The outcome of a sensation of itching and possible swelling in her throat was reported as recovered/resolved. The events of a sensation of itching and possible swelling in her throat were unknown related to GARDASIL. Additional information has been requested.